The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study. J of Skin [Internet]. 2020 Oct. 27 [cited 2025 Oct. 5];4(6):s93. Available from: https://skin.dermsquared.com/skin/article/view/1063